Wright Medical buys BioMimetic’s Platelet-Derived Growth Factor (PDGF) for $190M

By

Wright Medical to buy BioMimetic for $190M (Bloomberg)
Press Release from Wright
Medical device maker Wright Medical Group Inc. plans to buy BioMimetic Therapeutics Inc. in a $190 million cash-and-stock deal to help grow its foot and ankle business.
The companies said Monday the deal could grow to $380 million if some incentives are met.
Wright Medical, based in Arlington, Tenn., said it will pay $1.50 in cash and a portion of its stock for each share of BioMimetic. That totals $6.47 per share, based on Wright Medical's Friday closing price of $20.01.
That per-share price represents a premium...

Your friends are reading OrthoStreams daily - Are you ?

 

Unlock your access to full rich article, trends, hot startups, market reports and your daily newsletter.

Just $1/day.